Primary Objective: To develop a protocol for NMES for dysphagia to determine optimal electrode placement and stimulation parameters in MS patients.Secondary Objective: To determine variability in location, morphology, and type of motor dysfunctions…
ID
Source
Brief title
Condition
- Demyelinating disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
A protocol to determine optimal electrode placement and neuromuscular
electrical stimulation parameters for NMES for dysphagia in individual MS
patients.
Secondary outcome
The variability in location and type of motor dysfunctions of hyoid muscles in
patients with MS visualized with ultrasonography.
Background summary
The reported incidence of dysphagia in multiple sclerosis (MS) varies between
33% and 90% and is higher in more disabled patients. Dysphagia is associated
with an increased risk of aspiration pneumonia, increase in health-care cost
and increase in mortality and a decrease of quality of life (QOL). Patients
with oropharyngeal swallowing problems are commonly referred to a
speech-therapist for further assessment and treatment.
Limited evidence is available for treatment of dysphagia in MS. A significant
decrease of dysphagia in MS after treatment with neuromuscular electrical
stimulation (NMES) was found, but in other studies the results of the effect of
NMES on dysphagia were inconsistent. Therefore, the need for research into the
optimal parameters for the application of NMES is clear.
Study objective
Primary Objective: To develop a protocol for NMES for dysphagia to determine
optimal electrode placement and stimulation parameters in MS patients.
Secondary Objective: To determine variability in location, morphology, and type
of motor dysfunctions of hyoid muscles visualized with ultrasonography in MS
patients.
With this pilot study we will be able to develop a protocol for the application
of NMES for dysphagia in order to find individualized optimal electrode
placement and stimulation characteristics based on location, morphology and
type of motor dysfunctions that are present. In a follow up study the effect of
the NMES in the treatment of dysphagia in MS patients will be tested in a
randomized controlled trial following the developed protocol.
Study design
An explorative fundamental study based on a convenience sample. The DYMUS will
be used to screen patients for dysphagia. Fiberoptic endoscopy (FEES) will be
assessed by a speech and language therapist to determine the severity of the
dysphagia. Within two weeks a proficient physiotherapist will use
ultrasonography to determine the location and assess the morphology of the
hyoid muscles. Immediately thereafter an experienced speech therapist will use
electrical stimulation to stimulate the hyoid muscles. Simultaneously,
ultrasonography will be used to guide optimal electrode placement and
stimulation characteristics. Displacement of the hyoid bone will be measured
and abnormalities in muscle contractions will be noted. For every electrode
position, optimal stimulation parameters (amplitude (*A), pulse duration and
frequency (Hz)) will be determined by noting the thresholds for muscle
contraction. The comfort of the patients during stimulation will be taken into
account in finding optimal stimulation parameters.
Intervention
The patients receive neuromuscular electrical stimulation during a test
setting.
Study burden and risks
Burden:
All examinations take place within clinical staff rooms and departments of
Nieuw Unicum.
The participants will have 2 or 3 contact moments to complete the entire
examination. The total duration of the study is approximately 4 weeks.
Time investment: 3 sessions of 15 + 60 + 10 = 85 minutes in total.
Risks:
FEES
Despite of the various advantages of FEES, this diagnostic procedure is not
without risks. The most probable consequences are discomfort, gagging and/or
vomiting, vasovagal syncope, epistaxis, mucosal perforation and laryngospasm.
Those consequences do not appear frequently. Langmore, Pelletier & Nelson
(1995) reported 2 incidences of laryngospasmen (0.03%), 4 vasovagal episodes
(0.06%) and 20 incidences of epistaxis (0.3%) in 6000 FEES examinations.
Ultrasonography
An ultrasound is a completely painless and harmless procedure.
NMES
NMES is a specialized non-invasive form of electrical stimulation therapy
designed to treat dysphagia. The electrical current may start off as a slight
tingling sensation and build to a pulling sensation. For NMES no associated
risks are known at this time (NICE, 2014). Side effects include redness and
irritation to the skin, which typically clears with topical moisturizer in 24
to 48 hours. Up to one day after NMES, myalgia of the hyoid muscles can be
experienced.
Zandvoortselaan 165
Amsterdam 2042XK
NL
Zandvoortselaan 165
Amsterdam 2042XK
NL
Listed location countries
Age
Inclusion criteria
(1) at least 18 years of age
(2) a confirmed diagnosis of MS
(3) a diagnosis of dysphagia determined by FEES characterized by incomplete hyoid movement.
Exclusion criteria
(1) individuals with other neurological disorders
(2) individuals with obstruction in nasal passage (FEES will not be possible)
(3) individuals with significant cognitive deficits who cannot follow instructions during FEES or are not able to provide feedback on sensing stimulation or pain in their head and neck and
(4) individuals who are medically not stable enough to be able to participate in FEES (e.g. pneumonia or fever)
(5) radiotherapy in head/neck area or oncology of head/neck area
(6) in case of heart problems, metal implants in head/neck area, inflamed skin, implanted stimulators or electronic devices participation should be evaluated by a medical doctor.
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
CCMO | NL62007.029.17 |
OMON | NL-OMON29473 |